UA105278C2 - Способ получения каталитически активных антител (абзимов) с сиалидазной активностью - Google Patents

Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Info

Publication number
UA105278C2
UA105278C2 UAA201210528A UAA201210528A UA105278C2 UA 105278 C2 UA105278 C2 UA 105278C2 UA A201210528 A UAA201210528 A UA A201210528A UA A201210528 A UAA201210528 A UA A201210528A UA 105278 C2 UA105278 C2 UA 105278C2
Authority
UA
Ukraine
Prior art keywords
catalytically
active antibodies
production
sialidase activity
abzymes
Prior art date
Application number
UAA201210528A
Other languages
English (en)
Russian (ru)
Ukrainian (uk)
Inventor
Ростислав Олександрович Білий
Євгенія Євгенівна Біла
Юрій Ярославович Кіт
Original Assignee
Інститут Біології Клітини Нан України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Інститут Біології Клітини Нан України filed Critical Інститут Біології Клітини Нан України
Priority to UAA201210528A priority Critical patent/UA105278C2/ru
Priority to PCT/IB2013/001908 priority patent/WO2014037785A2/fr
Publication of UA105278C2 publication Critical patent/UA105278C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0002—Antibodies with enzymatic activity, e.g. abzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
UAA201210528A 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью UA105278C2 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
PCT/IB2013/001908 WO2014037785A2 (fr) 2012-09-06 2013-09-05 Anticorps catalytiques et leurs utilisations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Publications (1)

Publication Number Publication Date
UA105278C2 true UA105278C2 (ru) 2014-04-25

Family

ID=49885295

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201210528A UA105278C2 (ru) 2012-09-06 2012-09-06 Способ получения каталитически активных антител (абзимов) с сиалидазной активностью

Country Status (2)

Country Link
UA (1) UA105278C2 (fr)
WO (1) WO2014037785A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102581747B1 (ko) * 2016-07-01 2023-09-22 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 표적 세포 표면 편집을 위한 접합체
AU2019205912A1 (en) 2018-01-03 2020-07-16 Palleon Pharmaceuticals Inc. Recombinant human sialidases, sialidase fusion proteins, and methods of using the same

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
JPS5896026A (ja) 1981-10-30 1983-06-07 Nippon Chemiphar Co Ltd 新規ウロキナ−ゼ誘導体およびその製造法ならびにそれを含有する血栓溶解剤
CH652145A5 (de) 1982-01-22 1985-10-31 Sandoz Ag Verfahren zur in vitro-herstellung von hybridomen welche humane monoklonale antikoerper erzeugen.
DE3380726D1 (en) 1982-06-24 1989-11-23 Japan Chem Res Long-acting composition
US4766106A (en) 1985-06-26 1988-08-23 Cetus Corporation Solubilization of proteins for pharmaceutical compositions using polymer conjugation
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
CA1294215C (fr) 1986-10-27 1992-01-14 Ze'ev Shaked Compositions pharmaceutiques d'interferon beta recombinant et methodes de formulation
CA1292686C (fr) 1986-10-27 1991-12-03 Ze'ev Shaked Compositions pharmaceutiques d'interleukine-2 recombinante et procede de fabrication
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO1991010448A1 (fr) 1990-01-19 1991-07-25 German Cancer Research Center Antigene de surface cellulaire associe a l'apoptose cellulaire
US5463028A (en) 1992-04-03 1995-10-31 The Trustees Of Columbia University In The City Of New York Reagents for generating a polyclonal hydrolytic antibody response against cocaine and the monoclonal hydrolytic antibodies against cocaine derived through these reagents
US5770208A (en) 1996-09-11 1998-06-23 Nabi Staphylococcus aureus B-linked hexosamine antigen
US6268488B1 (en) * 1999-05-25 2001-07-31 Barbas, Iii Carlos F. Prodrug activation using catalytic antibodies
FR2825154B1 (fr) * 2001-05-22 2004-01-30 Univ Compiegne Tech Composes capables de moduler l'activite et de stimuler la production d'un anticorps catalytique
ES2486269T3 (es) * 2001-10-22 2014-08-18 The Scripps Research Institute Compuestos que eligen anticuerpos como diana
US20030087435A1 (en) 2001-11-06 2003-05-08 Brandt Jeffrey J. Catalytic antibodies raised against sarin; an organophosphorous anticholinesterase, and an antigen and process for the preparation thereof
DE60331310D1 (de) 2002-06-26 2010-04-01 Univ Louisville Res Found Verfahren zum apoptosenachweis
US20060074047A1 (en) * 2004-10-06 2006-04-06 Cross Alan S Method of treating inflammation with inhibitors of sialyl transferases
CA2624772C (fr) 2005-10-11 2011-11-29 Centre National De La Recherche Scientifique (Cnrs) Composes et ensembles pour la detection et le dosage de l'apoptose cellulaire
WO2007053654A2 (fr) 2005-10-31 2007-05-10 Cedars-Sinai Medical Center Procede d'agglutination pour la detection rapide, l'isolement et la quantification de cellules apoptotiques

Also Published As

Publication number Publication date
WO2014037785A2 (fr) 2014-03-13
WO2014037785A3 (fr) 2014-05-01

Similar Documents

Publication Publication Date Title
AR093377A1 (es) Anticuerpos anti-notch y conjugados de anticuerpo-farmaco
AR088322A1 (es) Anticuerpos anti-htra1 y metodos de uso
AR090017A1 (es) Agonistas de fgfr1 y sus metodos de uso
AR091098A1 (es) ANTICUERPOS E INMUNOCONJUGADOS CONTRA Ly6E Y METODOS DE USO
EP2894242A4 (fr) Cristal de complexe polymère-métal enveloppant un composé client, son procédé de fabrication, procédé de préparation d'un échantillon pour analyse de structure cristalline et procédé de détermination de la structure moléculaire d'un composé organique
WO2013060867A3 (fr) Production de protéines hétérodimères
CL2015001088A1 (es) Proceso de elaboración de compuestos derivados de pirimidina (div. sol. 850-13).
EA201492057A1 (ru) Ферментация и способ с псевдодвижущимся слоем
EA201490895A1 (ru) Производство сахарного спирта из биомассы
SG11201403204TA (en) Process for making hmf and hmf derivatives from sugars, with recovery of unreacted sugars suitable for direct fermentation to ethanol
AU2012312028A8 (en) Detection of isotype profiles as signatures for disease
MX345069B (es) Método para la producción de ligandos beta amiloide marcados con 18f.
BR112014013862A2 (pt) processos incluindo de alta produtividade, para fermentar gás de síntese
EP2580339A4 (fr) Système et procédé de production de biocarburants
EP3074036A4 (fr) Préparation d'anticorps à partir de cultures de cellules cho pour la conjugaison
DK3342867T3 (da) Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose
SG11201505171PA (en) Method for improving yield of enzymatic preparation of biodiesel from greases
IN2014DN09097A (fr)
UA105278C2 (ru) Способ получения каталитически активных антител (абзимов) с сиалидазной активностью
HK1215244A1 (zh) 用於製備 -溴- -氧雜二環 辛烷- -酮的方法
MY164628A (en) Catalytic cracking catalyst
HK1204011A1 (en) Method for the production of furan derivatives from glucose d-
WO2014008172A3 (fr) Lignée cellulaire en suspension à haut rendement, son système et son procédé de production
MX2012014118A (es) Metodo para la produccion de ligandos beta amiloide marcados con 18f.
MX349985B (es) Procedimiento de preparación de ésteres de fenilacetil aminoácido espirocíclicos con sustitución cis-alcoxi y derivados de 1h-pirrolidin-2,4-diona espirocicíclicos con sustitución cis-alcoxi.